These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
    Author: Pollard JR.
    Journal: Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537.
    Abstract:
    UCB SA was developing the high-affinity synaptic vesicle glycoprotein 2A ligand, seletracetam, an analog of levetiracetam, for the potential oral treatment of epilepsy. Phase II epilepsy trials were underway, but in July 2007, the company stated that development of seletracetam had been put on hold and it is unknown whether planned phase IIb/III trials will begin.
    [Abstract] [Full Text] [Related] [New Search]